10-K: ReposiTrak Reports Strong FY25 Growth, Dividend Hike

ReposiTrak, Inc. announced an 11% revenue increase and a 25% rise in net income for fiscal year 2025, alongside a 10% dividend increase and continued Preferred Stock redemptions.

Summary

• Revenue for the fiscal year ended June 30, 2025, increased by 11% to $22,606,066, up from $20,453,320 in FY24.
• Net income for the fiscal year ended June 30, 2025, rose by 25% to $6,978,127, compared to $5,598,290 in FY24.
• Basic earnings per share increased to $0.36 in FY25 from $0.30 in FY24, and diluted earnings per share increased to $0.35 from $0.29.
• The quarterly cash dividend was increased by 10% to $0.02 per share ($0.08 annually), effective for the quarter ending September 30, 2025.
• Cash and cash equivalents grew by 14% to $28,568,805 at June 30, 2025, from $25,153,862 at June 30, 2024.
• Working capital improved by $3,397,657, reaching $28,154,682 at June 30, 2025.
• The $10.0 million revolving credit facility with U.S. Bank N.A. was terminated in March 2024, resulting in zero bank debt as of June 30, 2025.
• The company continued its redemption and retirement of Series B Preferred Stock, with $3.2 million remaining to be redeemed.
• The compliance deadline for FSMA 204 was extended by 30 months to July 20, 2028.

Sentiment

Score: 8

Explanation: ReposiTrak demonstrated robust financial growth in revenue and net income, significantly improved its cash position and working capital, and eliminated bank debt. The dividend increase signals management confidence. Its strategic focus on food safety and traceability aligns with strong industry trends and regulatory drivers. However, increased operating expenses and the extended FSMA deadline present some headwinds.

Positives

• Revenue increased by 11% year-over-year, driven by growth in recurring subscription revenue across all business lines (compliance, supply chain, and traceability).
• Net income saw a significant 25% increase year-over-year, reflecting enhanced profitability.
• Cash and cash equivalents grew by 14% to $28.57 million, indicating strong liquidity and financial health.
• Working capital improved by $3.4 million, further strengthening the company's financial position.
• A 10% increase in the quarterly cash dividend to $0.02 per share ($0.08 annually) signals management's confidence in future performance and commitment to shareholder returns.
• The company successfully terminated its revolving credit facility in March 2024, achieving zero bank debt and increasing financial flexibility.
• Ongoing redemption of Preferred Stock reduces future dividend obligations and simplifies the capital structure.
• No single customer accounted for more than 10% of total revenue in FY25, indicating a diversified customer base.
• Proactive cybersecurity measures are in place, and no material cybersecurity threats have been identified to date.

Negatives

• Operating expenses increased across all categories: Cost of service and product support rose by 8%, Sales and marketing by 6%, General and administrative by 5%, and Depreciation and amortization by 5%.
• Sales and marketing expenses increased due to higher salary, commission, trade show, and FSMA 204 traceability marketing costs, although these are expected to flatten over the next twelve months.
• General and administrative expenses increased due to higher salary, stock compensation, employee benefits, insurance, bad debt, and travel-related costs.
• The 30-month extension of the FSMA 204 compliance deadline to July 20, 2028, may slow the adoption of the company's traceability technology, potentially impacting revenue growth.
• Future interest income on existing cash balances is unlikely to be maintained at current levels if the Federal Reserve cuts rates, unless additional credit risk is assumed.
• Common Stock share repurchases decreased significantly in FY25 ($200,035) compared to FY24 ($1,515,574).

Risks

• No assurance that revenue growth will continue or that the company will operate profitably in the future.
• Dependence on the continued services of founder and CEO, Randall K. Fields, whose loss could negatively impact operations.
• Quarterly and annual operating results may fluctuate due to factors such as customer retention, renewal rates, pricing changes, new product introductions, competition, economic conditions, and system failures.
• Threats from competing and emerging technologies, and larger competitors with greater financial and operational resources, could affect revenue growth and profitability.
• Risks associated with new product introductions, including difficulty in predicting necessary resources, technological issues in data capture, negative customer experiences, and implementation delays.
• Inability to accurately predict renewal or upgrade rates, which could decline due to customer dissatisfaction, economic conditions, or competitive solutions.
• If compliance and food safety solutions do not perform as expected, it could impair operating results and reputation, or lead to litigation.
• Risk of being joined in lawsuits if a customer is sued due to a recalled product, potentially incurring substantial defense costs and adverse effects on results.
• Risks associated with proprietary protection of software, including competitors independently developing equivalent technologies, unauthorized copying, and enforceability of licenses.
• Discovery of software errors (bugs) could result in revenue loss, reputational damage, or substantial liability, especially if third-party software defects are involved.
• Interruptions or delays in service from the third-party data center hosting facility could impair service delivery, reduce revenue, and harm business reputation.
• Security breaches and other disruptions could compromise customer data, company data, or IT systems, leading to loss of confidence, litigation, and financial exposure.
• A delay in the deadline for compliance with FSMA 204 may slow the adoption of the company's technology, negatively affecting revenue.
• Weakened global economic conditions, including inflationary fluctuations, could adversely affect the industry, business, and operating results by impacting IT spending.
• Geopolitical conflicts could affect sales and disrupt operations of the company or its customers.
• Volatility in the price of Common Stock due to fluctuating quarterly results.
• Limited public market for Common Stock may adversely affect an investor's ability to liquidate an investment.
• Future issuances of shares may lead to dilution in value, reduction in shareholder voting power, and may prevent a change in control.
• Officers and directors have significant control (40% of Common Stock, CEO Randall K. Fields controls 34%), which may lead to conflicts with other stockholders.
• Corporate charter authorizes unissued blank check Preferred Stock, issuable without stockholder approval, with the effect of diluting current stockholder interests.
• No assurance that quarterly dividends will continue to be paid, as the Board may elect to retain earnings for business development.
• Officers and directors have limited liability and indemnification rights under organizational documents, which may limit stockholder recourse.

Future Outlook

ReposiTrak expects to continue declaring and paying quarterly cash dividends, subject to board review of financial conditions and capital requirements. Management anticipates that the increase in marketing costs will flatten over the next twelve months as the traceability regulatory deadline approaches. The company intends to redeem all remaining outstanding Preferred Stock on or before December 2026. Management believes cash flow from operations and working capital will continue to increase, though this will be offset by funding dividends and Preferred Stock redemptions. The company plans to expand its offshore workforce to enhance analytics and professional services. Interest income on cash balances may not be maintained at current levels if the Federal Reserve cuts rates, without taking on additional credit risk. New FASB ASUs on income tax disclosures and disaggregation of income statement expenses are expected to impact disclosures but not the consolidated financial statements.

Management Comments

• Our processes are designed to assess, identify, and manage risks from potential unauthorized occurrences on or through our information technology systems.
• As of the date of this report, we have not identified cybersecurity threats that have materially affected, or are reasonably likely to materially affect, our business, results of operations, or financial condition.
• We believe the uptick in marketing costs will flatten over the next twelve months as awareness of the traceability regulatory deadline approaches.
• Although no assurances can be given, we continue to focus our sales efforts on marketing our software services on a recurring subscription basis and placing less emphasis on transactional revenue.
• Management currently believes that the Company will continue to increase its cash flow from operations and working capital position in subsequent periods.
• Although no assurances can be given, the Company intends to redeem all of the outstanding remaining Preferred stock on or before December 2026.

Industry Context

The U.S. consumer retail sector, encompassing food, convenience stores, and general merchandise, is experiencing significant pressures from the rise of online retailers, increased regulatory and tort risks (particularly in food safety due to FSMA), and consumer demand for greater product diversity and localized vendors. The FDA's 'New Era of Smarter Food Safety' blueprint and the FSMA Section 204(d) rule on traceability for high-risk foods are mandating extensive data capture and sharing across the food supply chain. This regulatory push, combined with major retailers implementing their own more stringent traceability programs (e.g., for all foods, with accelerated timelines), is driving the industry towards comprehensive traceability solutions. ReposiTrak, with its core expertise in supply chain data management and its ReposiTrak Traceability Network (RTN), is strategically positioned to capitalize on this growing demand, offering solutions designed to meet and exceed these evolving regulatory and competitive requirements.

Comparison to Industry Standards

• Major retailers are implementing food traceability programs with more robust requirements than the FDA's FSMA 204, including additional electronic data elements for every shipment, traceability for all foods (not just the Food Traceability List), and accelerated timelines (some requiring compliance by June 30, 2025, years before FDA enforcement).
• ReposiTrak positions its Traceability Network (RTN) as 'the largest connected network of food suppliers, wholesalers and retailers in the world,' implying a leading market position in this specialized segment.
• The company aims to develop a traceability solution that is 'easy, inexpensive and meets FDAs requirements,' suggesting a competitive advantage in terms of cost-effectiveness and user-friendliness compared to other market offerings.

Corporate Governance

Legal Proceedings

• The company is involved in various legal proceedings incidental to its business from time to time. Historically, these have not had a material adverse effect on its business, financial condition, results of operations, or liquidity. There are no pending or threatened material legal proceedings at this time.

Related Party Transactions

• The company continued a Service Agreement with Fields Management, Inc. (FMI), controlled by CEO Randall K. Fields, for executive management services. Payments to FMI were $1,025,617 in FY25 and $969,804 in FY24.
• The company redeemed and retired $2,937,749 in Series B Preferred Stock in FY25 from Mr. Randall K. Fields, his affiliates, and Robert W. Allen (a director).
• In FY24, the company redeemed and retired $95,284 in Series B Preferred Stock and $2,272,701 in Series B-1 Preferred Stock from Mr. Randall K. Fields, his affiliates, and Robert W. Allen.

Stakeholder Impact

• Shareholders: Positive impact from increased dividends, strong financial performance (revenue, net income, cash flow), and ongoing share repurchase program. Potential dilution risk from future stock issuances and blank check preferred stock. Reduced preferred stock obligations benefit common shareholders.
• Employees: Continued expansion of offshore workforce, potential for stock-based compensation under the 2023 Omnibus Equity Incentive Plan and 2023 Employee Stock Purchase Plan.
• Customers: Benefit from enhanced compliance, traceability, and supply chain management solutions, particularly with the ReposiTrak Traceability Network addressing FSMA 204 and retailer-driven traceability requirements. Improved information security services.
• Suppliers: Required to utilize ReposiTrak's services by 'Hubs' (retailers/wholesalers), indicating a captive market for ReposiTrak but a compliance burden for suppliers.
• Creditors: Positive impact from zero bank debt and strong liquidity, reducing credit risk.

Next Steps

• Pay the increased quarterly cash dividend of $0.02 per share on or about November 14, 2025, to shareholders of record as of September 30, 2025.
• File the definitive proxy statement with the SEC on or before October 28, 2025.
• Continue to declare and pay quarterly cash dividends, subject to periodic board review of financial condition and results of operations.
• Redeem all outstanding remaining Preferred Stock on or before December 2026.
• Continue expanding the offshore workforce to augment analytics services, professional services, and programming resources.
• Monitor and adapt to potential impacts of Federal Reserve rate cuts on interest income from cash balances.
• Complete the Research & Development Tax Study before filing the current tax return to apply additional tax credits.
• Adopt new FASB ASU 2023-09 (Improvements to Income Tax Disclosures) for annual reporting in fiscal year 2026.
• Adopt new FASB ASU 2024-03 (Disaggregation of Income Statement Expenses) for annual reporting in fiscal year 2028.

Key Dates

Recommendation

ReposiTrak's strong financial performance, including double-digit revenue and net income growth, coupled with a healthy balance sheet (zero bank debt, increased cash and working capital), indicates robust operational execution. The dividend increase and ongoing preferred stock redemptions demonstrate management's confidence and commitment to shareholder returns. The company is strategically positioned in the growing and regulatory-driven food safety and traceability market, with its ReposiTrak Traceability Network addressing critical industry needs and retailer demands. While increased operating expenses and the extended FSMA deadline are noted, the overall trajectory and market opportunity suggest continued positive momentum.

Keywords

Software-as-a-Service, SaaS, B2B e-commerce, supply chain management, compliance, traceability, food safety, FSMA 204, FDA, retail, wholesale, distribution, food industry, enterprise software, cloud-based, TRAK, ReposiTrak